October 30, 2015 / 2:07 PM / in 2 years

Ackman faults Valeant's reaction to short-seller allegations

BOSTON, Oct 30 (Reuters) - Hedge fund mogul William Ackman told his investors on Friday that he was confident in his bet on Valeant Pharmaceuticals, but faulted the company for a weak response to a short-seller’s allegations it is improperly inflating revenues.

He said during a teleconference that Valeant had made a “meaningful mistake” of underinvesting in its public relations, offering only a curt denial of short-seller Citron’s claims this month it used phantom sales to boost its bottom line.

Ackman’s Pershing Square Capital Management hedge fund is one of Valeant’s top investors, and has taken a big hit due to Valeant’s falling share price. (Reporting by Svea Herbst-Bayliss; Editing by Richard Valdmanis)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below